Latigo Biotherapeutics Inc.
NASDAQ:LTGOMedical - Pharmaceuticals
+$0.76 today
- Market cap
- $800.64M
- Beta
- 0.00
Volume 0.21M
Average 0.38M
LTGO EPS (Diluted)
Earnings per share assuming conversion of dilutive securities such as options and convertible instruments.
EPS (Diluted) history
Currency unavailable · from the income statement
No EPS (Diluted) data reported for this period type.
EPS (Diluted) vs competitors
How LTGO compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Mar 2026 | $2.04 USD | +68.1% | — | |
| LTM Mar 2026 | $0.12 USD | +105.3% | -22.2% | |
| LTM Mar 2026 | -$38.87 USD | -148.5% | — | |
LTGOLatigo Biotherapeutics Inc. | — | — | — | — |
| Peer median (excluding LTGO) | — | +68.1% | -22.2% | |
Competitors are the stored peer set for LTGO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Latigo Biotherapeutics Inc.
NASDAQ:LTGO
Intrinsic Alpha fair value
Locked
Current Price
$13.31
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.